Increased incidence of FMO1 gene single nucleotide polymorphisms in sporadic amyotrophic lateral sclerosis

Cristina Cereda1, Elisa Gabanti, Manuel Corato

  • 1Experimental Neurobiology, Neurological Institute IRCCS C Mondino, Pavia, Italy. cristina.cereda@mondino.it

Insights

Flavin-containing monooxygenase 1 (FMO1) gene variants may increase susceptibility to sporadic Amyotrophic Lateral Sclerosis (ALS). This study found specific FMO1 polymorphisms more prevalent in male ALS patients, suggesting a potential genetic link to the disease.

Area of Science:

  • Biochemistry
  • Genetics
  • Neuroscience

Background:

  • Flavin-containing monooxygenases (FMOs) are crucial for metabolizing xenobiotics and drugs.
  • FMOs also play a role in maintaining cellular redox balance by oxidizing glutathione.
  • Impaired redox balance is implicated in neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS).

Purpose of the Study:

  • To investigate the association between FMO1 gene single nucleotide polymorphisms (SNPs) and sporadic ALS (SALS).
  • To determine if specific FMO1 variants are more common in SALS patients compared to healthy controls.

Main Methods:

  • Analysis of allelic and genotypic frequencies of two 3' untranslated region (3'UTR) SNPs in the FMO1 gene.
  • Comparison between SALS patients and a healthy control group.
  • Techniques used included Single-Strand Conformation Polymorphism (SSCP) and direct sequencing.

Main Results:

  • A significantly higher frequency of two specific FMO1 3'UTR polymorphisms was observed in SALS patients.
  • This increased frequency was exclusive to the male population.
  • The findings suggest a potential sex-specific genetic association with ALS.

Conclusions:

  • Specific allelic variants of the FMO1 gene may be associated with an increased susceptibility to developing sporadic ALS.
  • The observed association appears to be sex-dependent, highlighting potential differences in genetic risk factors for ALS.
  • Further research is warranted to elucidate the functional impact of these FMO1 variants in ALS pathogenesis.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...